Related Experiment Video
Updated: Oct 22, 2025

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
Thymic hyperplasia after mRNA based Covid-19 vaccination.
Julia von Tresckow1, Bastian von Tresckow1, H Christian Reinhardt1
1Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Positron emission tomography/computed tomography scans can show increased 18F-Fluordeoxyglucose uptake in the thymus after mRNA COVID-19 vaccination. This finding is crucial for differentiating immune responses from disease involvement in cancer patients.
Area of Science:
- Oncology
- Immunology
- Radiology
Background:
- mRNA COVID-19 vaccines (BNT162B2, mRNA-1273) are known to cause reactive lymphadenopathy with increased 18F-Fluordeoxyglucose (FDG) uptake on PET/CT scans.
- Distinguishing between vaccine-induced immune responses and disease progression is critical for accurate patient management, especially in oncology.
Purpose of the Study:
- To report a case of increased thymic 18F-FDG uptake following mRNA COVID-19 vaccination.
- To highlight the importance of considering vaccination status when interpreting PET/CT findings in patients with cancer, particularly lymphoma.
Main Methods:
- Case report of a young patient with mantle cell lymphoma.
- Review of positron emission tomography/computed tomography (PET/CT) imaging findings.
Main Results:
- The patient exhibited increased 18F-FDG uptake in the thymus post-mRNA vaccination.
- This thymic uptake mimicked potential disease involvement, underscoring a diagnostic challenge.
Conclusions:
- Increased thymic 18F-FDG uptake can be a manifestation of immune response after mRNA vaccination.
- Awareness of this potential imaging finding is essential to prevent misdiagnosis and inappropriate treatment decisions in cancer patients.
More Related Videos
Related Concept Videos
Vaccinations
Humoral Immune Responses
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

